§ 69.41.120. Prescriptions to contain instruction as to whether or not a therapeutically equivalent generic drug may be substituted -- Out-of-state prescriptions -- Form -- Contents -- Procedure
Every drug prescription shall contain an instruction on whether or not a therapeutically equivalent generic drug may be substituted in its place, unless substitution is permitted under a prior-consent authorization.
If a written prescription is involved, the prescription must be legible and the form shall have two signature lines at opposite ends on the bottom of the form. Under the line at the right side shall be clearly printed the words "DISPENSE AS WRITTEN". Under the line at the left side shall be clearly printed the words "SUBSTITUTION PERMITTED". The practitioner shall communicate the instructions to the pharmacist by signing the appropriate line. No prescription shall be valid without the signature of the practitioner on one of these lines. In the case of a prescription issued by a practitioner in another state that uses a one-line prescription form or variation thereof, the pharmacist may substitute a therapeutically equivalent generic drug unless otherwise instructed by the practitioner through the use of the words "dispense as written", words of similar meaning, or some other indication.
If an oral prescription is involved, the practitioner or the practitioner's agent shall instruct the pharmacist as to whether or not a therapeutically equivalent generic drug may be substituted in its place. The pharmacist shall note the instructions on the file copy of the prescription.
The pharmacist shall note the manufacturer of the drug dispensed on the file copy of a written or oral prescription.
[2000 c 8 § 3; 1990 c 218 § 1; 1979 c 110 § 2; 1977 ex.s. c 352 § 3.]
Notes:
Findings -- Intent -- 2000 c 8: See note following RCW 69.41.010.
Sections: Previous 69.41.065 69.41.072 69.41.075 69.41.080 69.41.085 69.41.100 69.41.110 69.41.120 69.41.130 69.41.140 69.41.150 69.41.160 69.41.170 69.41.180 69.41.190 Next
Last modified: April 7, 2009